Recombinant Equine Interleukin-1 beta (rEqIL-1beta)

Official Full Name

Recombinant Equine Interleukin-1 beta (rEqIL-1beta)

Synonyms

IL-1 beta

Squence

Squence of Recombinant Equine Interleukin-1 beta

Amino Acid Sequence

AAMHSVNCRL RDIYHKSLVL SGACELQAVH LNGENTNQQV VFCMSFVQGE EETDKIPVAL GLKEKNLYLS CGMKDGKPTL QLETVDPNTY PKRKMEKRFV FNKMEIKGNV EFESAMYPNW YISTSQAEKS PVFLGNTRGG RDITDFIMEI TSA

Synonyms

IL-1 beta

Accession

Q28386

Gene ID

100034237

Summary

Interleukin-1 beta (IL-1β) is a non-secreted proinflammatory cytokine produced mainly by activated macrophages, as well as neutrophils, epithelial cells, and endothelial cells. It possesses metabolic, physiological, haematopoietic activities, and plays one of the central roles in the regulation of the immune responses. Both IL-1alpha and IL-1β binds to the same receptor and has similar but not identical biological properties. Recombinant equine interleukin-1 beta is a 17 kDa protein containing 153 amino acid residues and it shares 63 %~70 % a.a. sequence identity with canine, cotton rat, porcine, feline, human, mouse, rat, and rhesus IL1β.

Source

Escherichia coli.

Molecular Weight

Approximately 17.3 kDa, a single non-glycosylated polypeptide chain containing 153 amino acids.

Biological Activity

Fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using murine D10S cells is less than 20 pg/ml, corresponding to a specific activity of > 5.0 × 107 IU/mg.

Appearance

Sterile filtered white lyophilized (freeze-dried) powder.

Formulation

Lyophilized from a 0.2 um filtered concentrated solution in 1 × PBS, pH 7.4, 0.1 % Tween-80.

Endotoxin

Less than 1 EU/ug of rEqIL-1β as determined by LAL method.

Reconstitution

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/ml. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 12 months from date of receipt, -20 to -70 °C as supplied.- 1 month, 2 to 8 °C under sterile conditions after reconstitution.- 3 months, -20 to -70 °C under sterile conditions after reconstitution.

References

Purity

> 95 % by SDS-PAGE and HPLC analyses.

SDS-PAGE

SDS-PAGE of Recombinant Equine Interleukin-1 beta

Pack Size

10ug/100ug/500ug

Safety Data Sheet (SDS) Download

Click to download

Technical Data Sheet (TDS) Download

Click to download

Links

This product is branded by ChemWhat and sold through our website and here is the corresponding link Recombinant Equine Interleukin-1 beta (rEqIL-1beta) on ChemWhat